{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:31:15Z","timestamp":1791217875321,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1093\/eurheartj\/ehi478","type":"journal-article","created":{"date-parts":[[2005,9,3]],"date-time":"2005-09-03T00:24:17Z","timestamp":1125707057000},"page":"2193-2199","source":"Crossref","is-referenced-by-count":184,"title":["Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction"],"prefix":"10.1093","volume":"26","author":[{"given":"Paul","family":"Milliez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noeleen","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rucker-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Leenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Robidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Beaufils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Delcayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane N.","family":"Hatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,9,1]]},"reference":[{"key":"key\n\t\t\t\t20171011222549_EHI478C1","doi-asserted-by":"crossref","unstructured":"Li D, Fareh S, Leung TL, Nattel S. Promotion of atrial fibrillation by heart failure in dogs. Atrial remodeling of a different sort. Circulation1999;100:87\u201395.","DOI":"10.1161\/01.CIR.100.1.87"},{"key":"key\n\t\t\t\t20171011222549_EHI478C2","doi-asserted-by":"crossref","unstructured":"Boyden PA, Tilley LP, Albala A, Liu S-K, Fenoglio Jr JJ, Wit AL. Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. Circulation1984;69:1036\u20131047.","DOI":"10.1161\/01.CIR.69.5.1036"},{"key":"key\n\t\t\t\t20171011222549_EHI478C3","doi-asserted-by":"crossref","unstructured":"Aim\u00e9-Semp\u00e9 C, Folliguet T, R\u00fccker-Martin C, Krajewska M, Krajewska S, Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol1999;34:1577\u20131586.","DOI":"10.1016\/S0735-1097(99)00382-4"},{"key":"key\n\t\t\t\t20171011222549_EHI478C4","doi-asserted-by":"crossref","unstructured":"R\u00fccker-Martin C, Pecker F, Godreau D, Hatem S. Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro. Cardiovasc Res2002;55:38\u201352.","DOI":"10.1016\/S0008-6363(02)00338-3"},{"key":"key\n\t\t\t\t20171011222549_EHI478C5","doi-asserted-by":"crossref","unstructured":"Boixel C, Fontaine V, Rucker-Martin C, Milliez P, Louedec L, Michel JB, Jacob MP, Hatem SN. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in rat. J Am Coll Cardiol2003;42:336\u2013344.","DOI":"10.1016\/S0735-1097(03)00578-3"},{"key":"key\n\t\t\t\t20171011222549_EHI478C6","doi-asserted-by":"crossref","unstructured":"Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, Nattel S. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation1999;100:87\u201395.","DOI":"10.1161\/01.CIR.100.1.87"},{"key":"key\n\t\t\t\t20171011222549_EHI478C7","doi-asserted-by":"crossref","unstructured":"Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrical remodeling of the atria in congestive heart failure. Electrophysiological and electroanatomic mapping in humans. Circulation2003;108:1461\u20131468.","DOI":"10.1161\/01.CIR.0000090688.49283.67"},{"key":"key\n\t\t\t\t20171011222549_EHI478C8","doi-asserted-by":"crossref","unstructured":"Boixel C, Gonzalez W, Louedec L, Hatem SN. Mechanism of the down regulation of the L-type calcium current in atrial myocytes of rat in heart failure. Circ Res2001;89:607\u2013613.","DOI":"10.1161\/hh1901.096702"},{"key":"key\n\t\t\t\t20171011222549_EHI478C9","doi-asserted-by":"crossref","unstructured":"Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res2002;54:230\u2013246.","DOI":"10.1016\/S0008-6363(02)00258-4"},{"key":"key\n\t\t\t\t20171011222549_EHI478C10","doi-asserted-by":"crossref","unstructured":"Levy S, Breithardt G, Campbell RW, Camm AJ, Daubert JC, Allessie M, Aliot E, Capucci A, Cosio F, Crijns H, Jordaens L, Hauer RN, Lombardi F, Luderitz B. Atrial fibrillation: current knowledge and recommendations for management: Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J1998;19:1294\u20131320.","DOI":"10.1053\/euhj.1998.1050"},{"key":"key\n\t\t\t\t20171011222549_EHI478C11","doi-asserted-by":"crossref","unstructured":"Kannel WB, Abbot RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med1982;306:1018\u20131022.","DOI":"10.1056\/NEJM198204293061703"},{"key":"key\n\t\t\t\t20171011222549_EHI478C12","doi-asserted-by":"crossref","unstructured":"Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation. Very new insights into very old ideas. Annu Rev Physiol2000;62:51\u201377.","DOI":"10.1146\/annurev.physiol.62.1.51"},{"key":"key\n\t\t\t\t20171011222549_EHI478C13","doi-asserted-by":"crossref","unstructured":"Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation2001;104:2608\u20132614.","DOI":"10.1161\/hc4601.099402"},{"key":"key\n\t\t\t\t20171011222549_EHI478C14","doi-asserted-by":"crossref","unstructured":"Shi Y, Li D, Tardif JC, Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res2002;54:456\u2013461.","DOI":"10.1016\/S0008-6363(02)00243-2"},{"key":"key\n\t\t\t\t20171011222549_EHI478C15","doi-asserted-by":"crossref","unstructured":"Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventrciular dysfunction: insight from Studies of Left Ventricular Dysfunction (SOLVD) Trials. Circulation2003;107:2926\u20132931.","DOI":"10.1161\/01.CIR.0000072793.81076.D4"},{"key":"key\n\t\t\t\t20171011222549_EHI478C16","doi-asserted-by":"crossref","unstructured":"Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation2000;101:2612\u20132617.","DOI":"10.1161\/01.CIR.101.22.2612"},{"key":"key\n\t\t\t\t20171011222549_EHI478C17","doi-asserted-by":"crossref","unstructured":"Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction; effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation1999;99:2694\u20132701.","DOI":"10.1161\/01.CIR.99.20.2694"},{"key":"key\n\t\t\t\t20171011222549_EHI478C18","doi-asserted-by":"crossref","unstructured":"Wollert KC, Studer R, Doerfer K, Schieffer E, Holubarsch C, Just H, Drexler H. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation1997;95:1910\u20131917.","DOI":"10.1161\/01.CIR.95.7.1910"},{"key":"key\n\t\t\t\t20171011222549_EHI478C19","doi-asserted-by":"crossref","unstructured":"Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards. Subcommittee on quantification of two-dimensional echocardiograms. J Am Soc Echocardiogr1989;2:358\u2013367.","DOI":"10.1016\/S0894-7317(89)80014-8"},{"key":"key\n\t\t\t\t20171011222549_EHI478C20","doi-asserted-by":"crossref","unstructured":"Prunier F, Gaertner R, Louedec L, Michel JB, Mercadier JJ, Escoubet B. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol2002;283:346\u2013352.","DOI":"10.1152\/ajpheart.01050.2001"},{"key":"key\n\t\t\t\t20171011222549_EHI478C21","doi-asserted-by":"crossref","unstructured":"Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol1988;12:426\u2013440.","DOI":"10.1016\/0735-1097(88)90416-0"},{"key":"key\n\t\t\t\t20171011222549_EHI478C22","doi-asserted-by":"crossref","unstructured":"Goette A, Arndt M, Rocken C, Spiess A, Spiess A, Staack T, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation2000;101:2678\u20132681.","DOI":"10.1161\/01.CIR.101.23.2678"},{"key":"key\n\t\t\t\t20171011222549_EHI478C23","doi-asserted-by":"crossref","unstructured":"Bold A, Wetzel U, Weigl J, Garbade J, Lauschke J, Hindricks G, Kottkamp H, Gummert JF, Dhein S. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol2003;42:1785\u20131792.","DOI":"10.1016\/j.jacc.2003.07.014"},{"key":"key\n\t\t\t\t20171011222549_EHI478C24","doi-asserted-by":"crossref","unstructured":"Brooks WW, Bing OH, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat. Circulation1997;96:4002\u20134010.","DOI":"10.1161\/01.CIR.96.11.4002"},{"key":"key\n\t\t\t\t20171011222549_EHI478C25","doi-asserted-by":"crossref","unstructured":"Shinagawa K, Shi Y, Tardi JC, Leung TK, Nattel S. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dog. Circulation2002;105:2672\u20132678.","DOI":"10.1161\/01.CIR.0000016826.62813.F5"},{"key":"key\n\t\t\t\t20171011222549_EHI478C26","doi-asserted-by":"crossref","unstructured":"Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and independent pathways. Cardiovasc Res2003;60:315\u2013325.","DOI":"10.1016\/j.cardiores.2003.08.014"},{"key":"key\n\t\t\t\t20171011222549_EHI478C27","doi-asserted-by":"crossref","unstructured":"Delcayre C, Swynghedauw B. Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Mol Cell Cardiol2002;34:1577\u20131584.","DOI":"10.1006\/jmcc.2002.2088"},{"key":"key\n\t\t\t\t20171011222549_EHI478C28","doi-asserted-by":"crossref","unstructured":"Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: Insights from the Randomized Aldactone Evaluation Study (RALES). Circulation2000;102:2700\u20132706.","DOI":"10.1161\/01.CIR.102.22.2700"},{"key":"key\n\t\t\t\t20171011222549_EHI478C29","doi-asserted-by":"crossref","unstructured":"Pitt B. \u2018Escape\u2019 of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy. Cardiovasc Drugs Ther1995;9:145\u2013149.","DOI":"10.1007\/BF00877755"},{"key":"key\n\t\t\t\t20171011222549_EHI478C30","doi-asserted-by":"crossref","unstructured":"Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosterone-induced inflammation in the rat heart. Am J Pathol2002;161:1773\u20131781.","DOI":"10.1016\/S0002-9440(10)64454-9"},{"key":"key\n\t\t\t\t20171011222549_EHI478C31","doi-asserted-by":"crossref","unstructured":"Stockand JD, Meszaros JG. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1\/2 signaling. Am J Physiol Heart Circ Physiol2003;284:176\u2013184.","DOI":"10.1152\/ajpheart.00421.2002"},{"key":"key\n\t\t\t\t20171011222549_EHI478C32","doi-asserted-by":"crossref","unstructured":"Brilla C, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol1993;l25:563\u2013575.","DOI":"10.1006\/jmcc.1993.1066"},{"key":"key\n\t\t\t\t20171011222549_EHI478C33","doi-asserted-by":"crossref","unstructured":"Spach MS, Miller WT, Dolber PC, Kootsey JM, Sommer JR, Mosher CE. The functional role of structural complexities in the propagation of depolarization in the atrium of the dog: cardiac conduction disturbances due to discontinuities of effective axial resistivity. Circ Res1982;50:175\u2013191.","DOI":"10.1161\/01.RES.50.2.175"},{"key":"key\n\t\t\t\t20171011222549_EHI478C34","doi-asserted-by":"crossref","unstructured":"Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscles: evidence of electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res1986;58:356\u2013371.","DOI":"10.1161\/01.RES.58.3.356"},{"key":"key\n\t\t\t\t20171011222549_EHI478C35","doi-asserted-by":"crossref","unstructured":"Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, Hauer RN, Kirkels H, Janse MJ, de Bakker JM. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation2001;104:3069\u20133075.","DOI":"10.1161\/hc5001.100833"},{"key":"key\n\t\t\t\t20171011222549_EHI478C36","doi-asserted-by":"crossref","unstructured":"Goette A, Juenemann G, Peters G, Klein HU, Roessner A, Huth C, Rocken C. Determinants and consequences of atrial fibrosis in patient undergoing open heart surgery. Cardiovasc Res2002;54:390\u2013396.","DOI":"10.1016\/S0008-6363(02)00251-1"},{"key":"key\n\t\t\t\t20171011222549_EHI478C37","doi-asserted-by":"crossref","unstructured":"Gencel L, Poquet F, Gosse P, Haissaguerre M, Marcus FI, Clementy J. Correlation of signal-average P wave with electrophysiological testing for atrial vulnerability in strokes of unexplained etiology. Pacing Clin Electrophsyiol1994;17:2118\u20132124.","DOI":"10.1111\/j.1540-8159.1994.tb03811.x"},{"key":"key\n\t\t\t\t20171011222549_EHI478C38","doi-asserted-by":"crossref","unstructured":"Ouvrard-Pascaud A, Sainte-Marie Y, B\u00e9nitah JP, Perrier R, Soukaseum C, Nguyen A, Royer A, Le Quang K, Charpentier F, Demolombe S, Mechta-Grigoriou F, Beggah AT, Maison-Blanche P, Oblin ME, Delcayre C, Fishman GI, Farman N, Escoubet B, Jaisser F. Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation2005;111:3025\u20133033.","DOI":"10.1161\/CIRCULATIONAHA.104.503706"},{"key":"key\n\t\t\t\t20171011222549_EHI478C39","doi-asserted-by":"crossref","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol2005;45:1243\u20131248.","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"key\n\t\t\t\t20171011222549_EHI478C40","doi-asserted-by":"crossref","unstructured":"The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med1987;316:1429\u20131435.","DOI":"10.1056\/NEJM198706043162301"},{"key":"key\n\t\t\t\t20171011222549_EHI478C41","doi-asserted-by":"crossref","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure (The RALES study). N Engl J Med1999;341:709\u2013717.","DOI":"10.1056\/NEJM199909023411001"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/26\/20\/2193\/9625074\/ehi478.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T08:14:35Z","timestamp":1586420075000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/eurheartj\/article\/26\/20\/2193\/446883\/Spironolactone-reduces-fibrosis-of-dilated-atria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":41,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2005,9,1]]},"published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehi478","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,10]]},"published":{"date-parts":[[2005,9,1]]}}}